Targeting Transcriptional Regulators of CD8+ T Cell Dysfunction to Boost Anti-Tumor Immunity

Katherine A Waugh1, Sonia M Leach2, Jill E Slansky3

  • 1University of Colorado School of Medicine, 12800 East 19th Avenue, Mail Stop 8333, Aurora, CO 80045, USA. Katherine.Waugh@UCDenver.edu.

Vaccines
|September 23, 2015
PubMed

Insights

This review explores transcriptional pathways controlling tumor-infiltrating CD8+ T cells (TILs). Understanding these pathways can overcome T cell exhaustion and enhance immunotherapy effectiveness.

Area of Science:

  • Immunology
  • Molecular Biology
  • Cancer Research

Background:

  • Cellular environments significantly influence transcription, impacting cell function.
  • Genome-wide mRNA expression profiles reveal how pathways modulate cell behavior.
  • Tumor-infiltrating CD8+ T cells (TILs) are crucial for anti-tumor immunity but often become dysfunctional.

Purpose of the Study:

  • To review the transcriptional pathways that regulate the function of tumor-infiltrating CD8+ T cells (TILs).
  • To highlight how targeting overlapping inhibitory pathways can overcome TIL suppression mechanisms like exhaustion, tolerance, and anergy.
  • To emphasize the emerging understanding of transcriptional networks in TILs and their potential in immunotherapy.

Main Methods:

  • Review of existing literature on transcriptional regulation in CD8+ T cells.
  • Analysis of genome-wide mRNA expression profiles.
  • Focus on pathways modulating TIL function in various cellular environments.

Main Results:

  • Decades of research have established altered transcriptional networks in hypofunctional CD8+ T cells.
  • The specific relevance of these networks to TILs is a recent area of investigation.
  • Simultaneous inhibition of multiple overlapping pathways may restore TIL function against various suppressive mechanisms.

Conclusions:

  • Understanding TIL transcriptional pathways is critical for advancing cancer immunotherapy.
  • Recent technological progress enables deeper elucidation and application of these pathways.
  • Targeting these pathways offers a promising strategy to enhance TIL function and improve anti-tumor responses.

Related Concept Videos

Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
2.3K
Cytotoxic T Cells-mediated Immune Response01:27

Cytotoxic T Cells-mediated Immune Response

Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
8.3K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
9.1K
T Cell Activation and Clonal Selection01:22

T Cell Activation and Clonal Selection

T cells are integral to our adaptive immune system, recognizing and effectively responding to foreign antigens. T cell activation and clonal selection are pivotal in orchestrating this immune response. This article elucidates these mechanisms, detailing the roles of cluster of differentiation (CD) markers, major histocompatibility complex (MHC) molecules, costimulatory signals, and the process of clonal selection.
Naive T cells that have not yet encountered an antigen express two primary CD...
17.4K
T Cell Types and Functions01:24

T Cell Types and Functions

When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
3.3K